(Total Views: 508)
Posted On: 11/23/2025 8:46:57 PM
Post# of 158771
Re: sherlock57 #158633
I agree with all that.
I said the other day
Not one day will pass during the next 10 years in which Leronlimab will not be the focus of at least one trial.
How many trials will it end up participating in?
I bet a lot
I wonder if 10B up front for oncology is in the Ballpark after data, (at least the upreg), is hard to argue with?
How much after ICI does the trick on a few following L
How much would that drive additional value?
I said the other day
Not one day will pass during the next 10 years in which Leronlimab will not be the focus of at least one trial.
How many trials will it end up participating in?
I bet a lot
I wonder if 10B up front for oncology is in the Ballpark after data, (at least the upreg), is hard to argue with?
How much after ICI does the trick on a few following L
How much would that drive additional value?
(1)
(0)
